Together with physicians, other research groups, and industry partners, Fraunhofer MEVIS is developing software to optimize radiation therapy. The fifth clinical workshop to evaluate this software took place in Bremen on February 5 and 6.
Radiation therapy for cancer therapy usually lasts for several weeks. During this time, the situation of the patient changes often: bodyweight decreases, causing the tumor to shrink or change shape. As a result, the distribution of the radiation dose set at the beginning of the therapy is no longer optimal. In the worst case, the radiation can no longer fully hit the tumor, causing part of the radiation to reach and damage healthy tissue.
To avoid such a scenario, doctors have to adjust the direction and dose of the radiation according to current conditions. Until now, this replanning has been a costly and time-consuming procedure. The software developed in the BMBF-funded (Federal Ministry of Education and Research) SPARTA project aims at accelerating this process, thus offering cheaper therapy progress.
Fraunhofer Institute for Medical Image Computing MEVIS has contributed fast and accurate method of transferring the original planning situation to the current patient condition. To make the program as practical as possible, the experts from SPARTA work closely with doctors from renowned cancer clinics.
At the beginning of every radiation therapy, doctors develop a detailed treatment plan based on CT imagery. This plan indicates the body areas that must be irradiated, as well as how often and with what dosage they must be treated. The goal is to completely destroy the tumor while sparing nearby tissue as much as possible. However, this cannot be achieved with a single radiation session. Patients might undergo daily therapy for a month to successfully fight the cancer.
“To ensure that the tumor is targeted as planned, doctors take routine control images of the patient,” explains MEVIS researcher Stefan Wirtz. “That way, they can also recognize whether the patient is lying accurately in the device.” Likewise, these control images help determine whether the tumor has shifted in the body due to a patient´s weight loss over the course of therapy. In such cases, healthy body areas can be accidentally damaged by moving into the radiation path. “When treating tumors in the oral and pharyngeal cavity, the salivary gland sometimes shifts into the radiation area and can become damaged,” says Wirtz’ colleague Stefan Kraß.
To avoid this and to adjust the radiation optimally, doctors must compare the original planning images with the most recent control images. “Often, the doctor must view old and new images and compare them mentally,” Stefan Wirtz explains. “However, our software can align both of them in a single image and transfer the contours of the radiation area.” As a result, doctors can quickly recognize whether the original contours still apply to the current situation. If not, the contours can easily be adjusted with the software tools. “Until now, replanning radiation therapy could take several hours,” says Stefan Kraß. “Our software can accelerate the process considerably.”
To make the software user-friendly, MEVIS experts exchange ideas with radiation therapists several times a year and discuss progress during joint workshops. Is the program easy to operate? Do the algorithms deliver the proper results? Are the software tools as practical as the clinicians desire? “The doctors participate regularly,” emphasizes Wirtz. “This assures that our software will satisfy the demands of the clinical routine.”
One of SPARTA´s clinical project partners, the Ludwig Maximilian University (LMU) in Munich, has already implemented the program for research purposes to evaluate its benefits. “In the current version, the quick contour transfer generates very good re-contouring suggestions. The software will surely find its application in adaptive head and neck radiation therapy,” says LMU doctor Reinoud Nijhuis.
“When the project ends in March 2016, we want to present software that is by and large ready for practical use,” says Stefan Kraß, “and the software maturity achieved through close clinical collaboration might motivate the industry to want to market these results and address the necessary certification.”
The SPARTA project (Software Platform for Adaptive Multimodal Radio and Particle Therapy with Autarkic Extendibility) is funded by the German Federal Ministry of Education and Research (BMBF). It started on April 1, 2013 and will run for three years. The consortium encompasses ten partners, including research institutes, medical technology companies, and university clinics.
Dr. Guido Prause | Fraunhofer MEVIS - Institut für Bildgestützte Medizin
New discoveries predict ability to forecast dementia from single molecule
12.12.2018 | UT Southwestern Medical Center
Pain: Perception and motor impulses arise in the brain independently of one another
12.12.2018 | Technische Universität München
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences